Type
ArticleKAUST Grant Number
KUK-C1-013-04Date
2012-02Permanent link to this record
http://hdl.handle.net/10754/597300
Metadata
Show full item recordAbstract
A mathematical model of the interactions between a growing tumor and the immune system is presented. The equations and parameters of the model are based on experimental and clinical results from published studies. The model includes the primary cell populations involved in effector T-cell mediated tumor killing: regulatory T cells, helper T cells, and dendritic cells. A key feature is the inclusion of multiple mechanisms of immunosuppression through the main cytokines and growth factors mediating the interactions between the cell populations. Decreased access of effector cells to the tumor interior with increasing tumor size is accounted for. The model is applied to tumors with different growth rates and antigenicities to gauge the relative importance of various immunosuppressive mechanisms. The most important factors leading to tumor escape are TGF-Β-induced immunosuppression, conversion of helper T cells into regulatory T cells, and the limitation of immune cell access to the full tumor at large tumor sizes. The results suggest that for a given tumor growth rate, there is an optimal antigenicity maximizing the response of the immune system. Further increases in antigenicity result in increased immunosuppression, and therefore a decrease in tumor killing rate. This result may have implications for immunotherapies which modulate the effective antigenicity. Simulation of dendritic cell therapy with the model suggests that for some tumors, there is an optimal dose of transfused dendritic cells. © 2011 Elsevier Ltd.Citation
Robertson-Tessi M, El-Kareh A, Goriely A (2012) A mathematical model of tumor–immune interactions. Journal of Theoretical Biology 294: 56–73. Available: http://dx.doi.org/10.1016/j.jtbi.2011.10.027.Sponsors
This publication is based on the work supported by Award No. KUK-C1-013-04, made by King Abdullah University of Science and Technology (KAUST), and for based in part on the work supported by the National Science Foundation under grants DMS-0907773 (AG). AG is a Wolfson/Royal Society Merit Award Holder. This publication is based on the work supported by the ARCS Foundation, NSF-VIGRE, and the BIO5 Institute at the University of Arizona (MRT).Publisher
Elsevier BVJournal
Journal of Theoretical BiologyPubMed ID
22051568ae974a485f413a2113503eed53cd6c53
10.1016/j.jtbi.2011.10.027
Scopus Count
Collections
Publications Acknowledging KAUST SupportRelated articles
- Mechanisms of immune evasion by gliomas.
- Authors: Rolle CE, Sengupta S, Lesniak MS
- Issue date: 2012
- Immunosuppressive strategies that are mediated by tumor cells.
- Authors: Rabinovich GA, Gabrilovich D, Sotomayor EM
- Issue date: 2007
- Activated human CD4+ T cells induced by dendritic cell stimulation are most sensitive to transforming growth factor-beta: implications for dendritic cell immunization against cancer.
- Authors: Lin CM, Wang FH, Lee PK
- Issue date: 2002 Jan
- Immunosuppressive dendritic and regulatory T cells are upregulated in melanoma patients.
- Authors: McCarter MD, Baumgartner J, Escobar GA, Richter D, Lewis K, Robinson W, Wilson C, Palmer BE, Gonzalez R
- Issue date: 2007 Oct
- Regulatory T cell: a protection for tumour cells.
- Authors: Wang Y, Ma Y, Fang Y, Wu S, Liu L, Fu D, Shen X
- Issue date: 2012 Mar